Hoth Therapeutics Inc. (NASDAQ: HOTH) is -35.02% lower on its value in year-to-date trading and has touched a low of $1.41 and a high of $4.96 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HOTH stock was last observed hovering at around $1.46 in the last trading session, with the day’s gains setting it 0.08% off its average median price target of $10.00 for the next 12 months. It is also 84.6% off the consensus price target high of $10.00 offered by 1 analysts, but current levels are 84.6% higher than the price target low of $10.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $1.54, the stock is -19.65% and -28.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 40.9 million and changing 5.48% at the moment leaves the stock -28.66% off its SMA200. HOTH registered -50.64% loss for a year compared to 6-month gain of -13.97%. The firm has a 50-day simple moving average (SMA 50) of $2.2145 and a 200-day simple moving average (SMA200) of $2.0021.
The stock witnessed a -30.32% loss in the last 1 month and extending the period to 3 months gives it a -28.37%, and is -8.33% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.59% over the week and 10.24% over the month.
Distance from 52-week low is 9.22% and -68.95% from its 52-week high.
Hoth Therapeutics Inc. (HOTH) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Hoth Therapeutics Inc. (HOTH) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Hoth Therapeutics Inc. is expected to release its quarterly report on 08/19/2021 and quarterly earnings per share for the current quarter are estimated at -$0.09.The EPS is expected to grow by 30.70% this year.
Hoth Therapeutics Inc. (HOTH) Top Institutional Holders
18 institutions hold shares in Hoth Therapeutics Inc. (HOTH), with 6.27M shares held by insiders accounting for 27.54% while institutional investors hold 7.14% of the company’s shares. The shares outstanding are 13.45M, and float is at 6.70M with Short Float at 23.13%. Institutions hold 5.18% of the Float.
The top institutional shareholder in the company is Renaissance Technologies, LLC with over 0.16 million shares valued at $0.37 million. The investor’s holdings represent 0.69% of the HOTH Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 49687.0 shares valued at $0.12 million to account for 0.22% of the shares outstanding. The other top investors are Two Sigma Advisers, LP which holds 39700.0 shares representing 0.17% and valued at over $94089.0, while Citadel Advisors LLC holds 0.15% of the shares totaling 33593.0 with a market value of $79615.0.
Hoth Therapeutics Inc. (HOTH) Insider Activity
A total of 0 insider transactions have happened at Hoth Therapeutics Inc. (HOTH) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by Hayes Anthony, the company’s 10% Owner. SEC filings show that Hayes Anthony sold 400,000 shares of the company’s common stock on May 26 at a price of $1.25 per share for a total of $0.5 million. Following the sale, the insider now owns 1.13 million shares.